Company intelligence / Profile preview

Form Bio

Dallas, Texas, United Statesformbio.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

As a software/platform company, not directly generating clinical results but enabling accelerated discovery, optimization, and regulatory readiness for cell/gene therapies developed by customers. Demonstrated ability to improve manufacturability and safety profiles of AAV constructs via AI-driven approaches in collaboration with lab partners.

Therapeutic areas: Other
Modalities: Gene therapy (AAV-based)Cell therapy (enabling technology)Computational biology platform (enabling multiple modalities)
Industry: Drug Discovery Services

Partnerships

PacBio – Collaboration on AAV design/analysis resourcesGoogle Cloud – Premier Partner status for HCLS/multiomics segment integrationParabricks – Reference platform integration for accelerated genome sequencing

Beyond the preview

Go deeper on Form Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Form Bio.

Explore the full profile